Following the COVID-19 pandemic, the life sciences industry has undergone several changes. Face-to-face HCP interactions are slowly being replaced with an omnichannel approach; the market is also pivoting from centralized clinical trials to de-centralized clinical trial operations. Additionally, safety has become a priority for regulators and consumers, leading to increased focus on pharmacovigilance. The dynamic nature of this industry and recent disruptions have opened new growth avenues for enterprises. To capitalize on these opportunities, enterprises are investing in digital tools and establishing relationships with third-party vendors to achieve cost savings and operational efficiencies.

In this research, we present a detailed assessment of 32 operations service providers featured on the Life Sciences Operations – Services PEAK Matrix®. We provide a relative positioning and analysis of the providers’ market shares, along with our evaluation of their strengths and limitations. This report will enable enterprises to identify suitable service providers to manage the evolving needs of their businesses.

Scope

Industry: life sciences BPS

Geography: global

Contents

This report provides a detailed analysis of 32 operations service providers and includes:

• Relative positioning of the providers on Everest Group’s PEAK Matrix® for Life Sciences Operations Services
• Comparison of the providers’ capabilities and market shares
• Everest Group’s analysis of the providers’ strengths and limitations

Membership(s)

Life Sciences Business Process

Sourcing and Vendor Management